01/30/2026
A four-protein panel improved pancreatic cancer detection accuracy to 91.9%, outperforming the single CA19-9 protein.
The panel improved early-stage (I/II) detection to 87.5% across two patient cohorts versus 76.2% for CA19-9 alone.
Researchers recommend evaluating this multimarker panel in high-risk patients to establish its effectiveness in prediagnostic settings.